In addition, there was no significant reduction in myeloid infiltration per mm3 of the tumor in the setting of CaMKK2 deficiency, and there was instead a higher percentage of myeloid cells found intratumorally, rather than peritumorally (Supplementary Fig. 5d, e). This evidence concerns the gene CAMKK2 and neoplasm.